"If confirmed in larger studies, these medications could represent a new class of metabolic-based addiction treatments bridging endocrinology and behavioral health." CLICK HERE FOR MORE HEALTH STORIES "Its time to move beyond viewing them as 'weight-loss mania,'" the expert added
Raterink et al
Retatrutide showed 24% weight loss in trials impressive, but we need to understand the durability and real-world tolerability of these multi-hormone approaches
Popular GLP-1 medications include: Semaglutide (brand names like Ozempic, Wegovy) Liraglutide (Saxenda, Victoza) Dulaglutide (Trulicity) Their dual role in managing diabetes and obesity has expanded their use, leading to increased demand
PMID 30091808
Johansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, Andreassen TT, Wilken M, Orskov H